Robotic pelvic side-wall dissection and en-bloc excision for locally advanced and recurrent rectal cancer: outcomes on feasibility and safety
- PMID: 35555959
- DOI: 10.1111/ans.17757
Robotic pelvic side-wall dissection and en-bloc excision for locally advanced and recurrent rectal cancer: outcomes on feasibility and safety
Abstract
Background: Global differences exist in managing lateral pelvic nodes in rectal cancer. Recent studies demonstrate improved local recurrence rates in patients undergoing lateral pelvic lymph node dissections (LPND) in addition to total mesorectal excision (TME) for advanced lower rectal cancer. This study aims to report on the safety and feasibility of the robotic approach in patients undergoing pelvic sidewall lymph node dissection or en-bloc sidewall resection for advanced lower rectal cancer.
Methods: Patients who underwent an elective robotic pelvic sidewall lymph node dissection or en-bloc sidewall resection for locally advanced rectal cancer with suspicious lateral lymph nodes or pelvic side wall involvement between January 2018 and March 2021 were included. Demographic, clinical, perioperative and histopathological variables were recorded and analysed.
Results: Eight patients (3 males) with a mean age of 55 (33-73) years and mean body mass index of 26.3 (20.7-30.0) kg/m2 were included. The median operative time and blood loss were 458.75 (360-540) min and 143.75 (100-300) mL, respectively. There were no conversions or intra-operative complications. There were three post-operative complications recorded (two ileus and one anastomotic leak which required an endoscopic washout in theatre and intravenous antibiotics thereafter). Median length of stay was 12.75 (7-23) days. All patients had an R0 resection, and the median lateral pelvic lymph node yield was 9.1 (6-14).
Conclusion: This series demonstrates the practicality and the safety of the robotic approach in the introduction of this technique for en-bloc resection or LPND in patients with locally advanced rectal cancer.
Keywords: lateral pelvic lymph node dissection; pelvic sidewall; rectal cancer; robotic.
© 2022 Royal Australasian College of Surgeons.
Similar articles
-
Laparoscopic Versus Robotic Lateral Pelvic Lymph Node Dissection in Locally-Advanced Rectal Cancer: A Cohort Study Comparing Perioperative Morbidity and Short-Term Oncological Outcomes.Cancer Rep (Hoboken). 2025 Mar;8(3):e70174. doi: 10.1002/cnr2.70174. Cancer Rep (Hoboken). 2025. PMID: 40052270 Free PMC article.
-
Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.Tech Coloproctol. 2021 Apr;25(4):413-423. doi: 10.1007/s10151-020-02383-7. Epub 2021 Feb 16. Tech Coloproctol. 2021. PMID: 33594627
-
Robotic and laparoscopic salvage lateral pelvic node dissection for the treatment of recurrent rectal cancer.Surg Endosc. 2023 Jun;37(6):4954-4961. doi: 10.1007/s00464-023-10000-5. Epub 2023 Apr 4. Surg Endosc. 2023. PMID: 37016084
-
Robotic versus laparoscopic total mesorectal excision with lateral lymph node dissection for advanced rectal cancer: A systematic review and meta-analysis.PLoS One. 2024 May 29;19(5):e0304031. doi: 10.1371/journal.pone.0304031. eCollection 2024. PLoS One. 2024. PMID: 38809911 Free PMC article.
-
Lateral pelvic lymph node dissection in the management of locally advanced low rectal cancer: Summary of the current evidence.Surg Oncol. 2020 Dec;35:418-425. doi: 10.1016/j.suronc.2020.09.021. Epub 2020 Sep 28. Surg Oncol. 2020. PMID: 33038847 Review.
Cited by
-
Initial experience and results of robotic lateral pelvic lymph node dissection in locally advanced rectal cancer-a single center experience of 17 consecutive procedures.Int J Colorectal Dis. 2024 Dec 17;39(1):204. doi: 10.1007/s00384-024-04782-w. Int J Colorectal Dis. 2024. PMID: 39688615 Free PMC article.
-
Robotic Beyond Total Mesorectal Excision (bTME) for locally advanced and recurrent anorectal cancer: a systematic review.J Robot Surg. 2025 Jul 16;19(1):397. doi: 10.1007/s11701-025-02573-1. J Robot Surg. 2025. PMID: 40670732 Free PMC article. Review.
References
-
- MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
-
- Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br. J. Surg. 2005; 92: 756-63.
-
- Atef Y, Koedam TW, van Oostendorp SE, Bonjer HJ, Wijsmuller AR, Tuynman JB. Lateral pelvic lymph node metastases in rectal cancer: a systematic review. World J. Surg. 2019; 43: 3198-206.
-
- Otero de Pablos J, Mayol J. Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west? Front Surg [Internet]. 2020; 6: 79 [Cited 6 Mar 2021.] https://doi.org/10.3389/fsurg.2019.00079/full.
-
- Fujita S, Yamamoto S, Akasu T, Moriya Y. Lateral pelvic lymph node dissection for advanced lower rectal cancer. Br. J. Surg. 2003; 90: 1580-5.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials